E Raskopf

807 total citations
40 papers, 636 citations indexed

About

E Raskopf is a scholar working on Molecular Biology, Immunology and Allergy and Cancer Research. According to data from OpenAlex, E Raskopf has authored 40 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Immunology and Allergy and 11 papers in Cancer Research. Recurrent topics in E Raskopf's work include Allergic Rhinitis and Sensitization (12 papers), Angiogenesis and VEGF in Cancer (11 papers) and Asthma and respiratory diseases (9 papers). E Raskopf is often cited by papers focused on Allergic Rhinitis and Sensitization (12 papers), Angiogenesis and VEGF in Cancer (11 papers) and Asthma and respiratory diseases (9 papers). E Raskopf collaborates with scholars based in Germany, United Kingdom and Spain. E Raskopf's co-authors include Volker Schmitz, Tilman Sauerbruch, Annabelle Vogt, Ralph Mösges, Miroslaw Kornek, Christian Rabe, Matthias Ocker, Maria A. González-Carmona, Kija Shah‐Hosseini and Gisa Tiegs and has published in prestigious journals such as Hepatology, Gut and Scientific Reports.

In The Last Decade

E Raskopf

39 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Raskopf Germany 16 297 153 153 121 100 40 636
Marie‐Thérèse Simon France 12 210 0.7× 67 0.4× 70 0.5× 34 0.3× 179 1.8× 12 665
Eva Santamaría Spain 12 142 0.5× 39 0.3× 32 0.2× 48 0.4× 74 0.7× 29 394
Jèssica Mainez Spain 7 280 0.9× 117 0.8× 84 0.5× 24 0.2× 225 2.3× 9 563
Tatsuya Sasakawa Japan 12 291 1.0× 21 0.1× 32 0.2× 89 0.7× 68 0.7× 13 633
Stephen Ariyan United States 10 344 1.2× 22 0.1× 115 0.8× 29 0.2× 170 1.7× 15 847
Weihong Yin United States 12 254 0.9× 27 0.2× 107 0.7× 12 0.1× 98 1.0× 15 498
Natalie T. Meisler United States 15 230 0.8× 27 0.2× 49 0.3× 30 0.2× 36 0.4× 27 512
Avijit Majumdar United States 11 445 1.5× 56 0.4× 100 0.7× 10 0.1× 223 2.2× 13 628
Namratha Sheshadri United States 8 159 0.5× 28 0.2× 68 0.4× 11 0.1× 94 0.9× 10 395
Diego Maritano Italy 7 296 1.0× 43 0.3× 133 0.9× 27 0.2× 415 4.2× 9 772

Countries citing papers authored by E Raskopf

Since Specialization
Citations

This map shows the geographic impact of E Raskopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Raskopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Raskopf more than expected).

Fields of papers citing papers by E Raskopf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Raskopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Raskopf. The network helps show where E Raskopf may publish in the future.

Co-authorship network of co-authors of E Raskopf

This figure shows the co-authorship network connecting the top 25 collaborators of E Raskopf. A scholar is included among the top collaborators of E Raskopf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Raskopf. E Raskopf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mösges, Ralph, et al.. (2025). Patient-reported therapeutic benefits of herbal medicinal products in the treatment of gynecological ailments. BMC Complementary Medicine and Therapies. 25(1). 99–99. 1 indexed citations
2.
Mösges, Ralph, E Raskopf, Ludger Klimek, et al.. (2024). Short‐course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy. Allergy. 80(3). 817–826. 4 indexed citations
3.
Mösges, Ralph, E Raskopf, Cengizhan Açıkel, et al.. (2023). A randomized, double‐blind, placebo‐controlled trial with mannan‐conjugated birch pollen allergoids. Allergy. 79(4). 990–1000. 11 indexed citations
4.
Völp, Andreas, Jennifer Schmitz, Michael Bulitta, et al.. (2022). Ivy leaves extract EA 575 in the treatment of cough during acute respiratory tract infections: meta-analysis of double-blind, randomized, placebo-controlled trials. Scientific Reports. 12(1). 20041–20041. 9 indexed citations
5.
Becker, Sven, Petra Zieglmayer, Gabriela Cantó, et al.. (2021). A meta‐analysis on allergen‐specific immunotherapy using MCT® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis. Clinical and Translational Allergy. 11(4). e12037–e12037. 13 indexed citations
6.
Salapatek, Anne Marie, et al.. (2021). Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis. Clinical and Translational Allergy. 11(1). e12006–e12006. 16 indexed citations
7.
Nieber, K, E Raskopf, O Kelber, et al.. (2019). Pharmaco-epidemiological research on herbal medicinal products in the paediatric population: data from the PhytoVIS study. European Journal of Pediatrics. 179(3). 507–512. 8 indexed citations
8.
Schleicher, Sabine, et al.. (2019). Liposomal Eye Spray Is as Effective as Antihistamine Eye Drops in Patients with Allergic Rhinoconjunctivitis Induced by Conjunctival Provocation Testing. International Archives of Allergy and Immunology. 179(2). 123–131. 2 indexed citations
9.
Pieper‐Fürst, Ursula, et al.. (2018). Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy. Clinical and Translational Allergy. 8(1). 28–28. 4 indexed citations
10.
Shah‐Hosseini, Kija, et al.. (2017). RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients. Allergy. 73(5). 1101–1109. 11 indexed citations
11.
Uschner, Frank Erhard, Steve S. Choi, M Granzow, et al.. (2015). Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension. Scientific Reports. 5(1). 14573–14573. 42 indexed citations
12.
Raskopf, E, Annabelle Vogt, G. Anton Decker, et al.. (2012). Combination of Hypoxia and RNA-Interference Targeting VEGF Induces Apoptosis in Hepatoma Cells Via Autocrine Mechanisms. Current Pharmaceutical Biotechnology. 13(11). 2290–2298. 7 indexed citations
13.
Raskopf, E, Annabelle Vogt, Jens Standop, Tilman Sauerbruch, & Volker Schmitz. (2010). Inhibition of Neuropilin-1 by RNA-Interference and its Angiostatic Potential in the Treatment of Hepatocellular Carcinoma. Zeitschrift für Gastroenterologie. 48(1). 21–27. 18 indexed citations
14.
Raskopf, E, et al.. (2009). Plasminogen fragment K1–3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver. International Journal of Colorectal Disease. 24(7). 837–844. 4 indexed citations
16.
Kornek, Miroslaw, E Raskopf, René H. Tolba, et al.. (2008). Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro‐angiogenic and prometastatic factors in murine liver fibrosis. Liver International. 28(4). 509–518. 30 indexed citations
17.
Sass, Gabriele, Petra Leukel, Volker Schmitz, et al.. (2008). Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. International Journal of Cancer. 123(6). 1269–1277. 84 indexed citations
19.
Raskopf, E, Tobias Hilbert, Christian Rabe, et al.. (2005). Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model†. Hepatology. 41(6). 1233–1240. 31 indexed citations
20.
Schmitz, Volker, E Raskopf, Christian Rabe, et al.. (2005). Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model. International Journal of Colorectal Disease. 20(6). 494–501. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026